Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), manual, per specimen; each multiplex probe stain procedure

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), is a specialized laboratory technique utilized primarily by pathologists and geneticists to visualize and analyze specific genes or segments of genes within biological specimens. This method employs fluorescent tagging to detect and identify genetic abnormalities, which may include translocations, deletions, duplications, amplifications, and inversions on chromosomes, as well as in hematologic cells and solid tumor cancers. The insights gained from this analysis are crucial for determining patient eligibility for targeted therapies, planning treatment strategies, and monitoring the effectiveness of ongoing treatments. The procedure involves fixing cells onto a microscope slide and treating them to denature the DNA, converting it into single strands. Subsequently, multiple short sequences of single-stranded DNA, known as probes, which are complementary to the target gene(s), are tagged with fluorescent labels and applied to the slide. After allowing the probe DNA to hybridize with the slide DNA, the slide undergoes a washing process to eliminate any unbound probes. Finally, the slide is examined manually under a microscope to assess the presence of any genetic abnormalities, providing valuable information for clinical decision-making.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The morphometric analysis, in situ hybridization (quantitative or semi-quantitative) procedure is indicated for the following conditions:

  • Detection of Genetic Abnormalities This procedure is performed to identify specific genetic abnormalities such as translocations, deletions, duplications, amplifications, and inversions that may be present in chromosomes, hematologic cells, or solid tumors.
  • Assessment of Tumor Characteristics It is utilized to analyze the genetic makeup of tumors, which can provide insights into tumor behavior and potential treatment responses.
  • Eligibility for Targeted Therapies The results from this analysis can help determine whether a patient qualifies for specific targeted treatments based on the genetic alterations identified.
  • Monitoring Treatment Response This procedure can be used to monitor the effectiveness of ongoing treatments by assessing changes in genetic abnormalities over time.

2. Procedure

The morphometric analysis, in situ hybridization procedure involves several key steps that are critical for accurate results:

  • Step 1: Specimen Preparation The first step involves fixing the cells onto a microscope slide. This is essential to preserve the cellular structure and genetic material for analysis.
  • Step 2: DNA Denaturation The fixed cells are treated to denature the DNA, which means that the double-stranded DNA is separated into single strands. This step is crucial for allowing the probes to bind effectively to their complementary sequences.
  • Step 3: Probe Application Multiple short sequences of single-stranded DNA, known as probes, that are complementary to the target gene(s) are tagged with fluorescent labels. These probes are then applied to the slide containing the denatured DNA.
  • Step 4: Hybridization The slide is incubated to allow the probe DNA to hybridize, or bind, to the complementary sequences on the slide. This binding is essential for the subsequent detection of genetic abnormalities.
  • Step 5: Washing After hybridization, the slide undergoes a washing process to remove any excess, unbound probes. This step ensures that only the specifically bound probes remain attached to the target DNA.
  • Step 6: Microscopic Examination Finally, the slide is viewed manually under a microscope. The pathologist or geneticist examines the slide to determine the presence of any genetic abnormalities based on the fluorescent signals emitted by the bound probes.

3. Post-Procedure

Post-procedure care for morphometric analysis, in situ hybridization typically involves ensuring that the results are accurately documented and communicated to the relevant healthcare providers. The findings from the analysis may require further interpretation and discussion in the context of the patient's overall clinical picture. Additionally, any necessary follow-up testing or treatment plans should be established based on the results obtained from the procedure. It is important for healthcare professionals to monitor the patient’s response to any treatments initiated as a result of the findings from this analysis.

Short Descr M/PHMTRC ALYS ISHQUANT/SEMIQ
Medium Descr M/PHMTRC ALYS ISH QUANT/SEMIQ MNL EACH MULTIPRB
Long Descr Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), manual, per specimen; each multiplex probe stain procedure
Status Code Active Code
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 1 - Diagnostic Tests for Radiology Services
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator STV-Packaged Codes
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1G - Lab tests - other (Medicare fee schedule)
MUE 5

This is a primary code that can be used with these additional add-on codes.

0853T Add On Code Resequenced Code MPFS Status: Carrier Priced APC N Digitization of glass microscope slides for morphometric analysis, in situ hybridization (quantitative or semiquantitative), manual, per specimen; each multiplex probe stain procedure (List separately in addition to code for primary procedure)
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
TC Technical component; under certain circumstances, a charge may be made for the technical component alone; under those circumstances the technical component charge is identified by adding modifier 'tc' to the usual procedure number; technical component charges are institutional charges and not billed separately by physicians; however, portable x-ray suppliers only bill for technical component and should utilize modifier tc; the charge data from portable x-ray suppliers will then be used to build customary and prevailing profiles
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
GZ Item or service expected to be denied as not reasonable and necessary
GC This service has been performed in part by a resident under the direction of a teaching physician
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
76 Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
XE Separate encounter, a service that is distinct because it occurred during a separate encounter
XP Separate practitioner, a service that is distinct because it was performed by a different practitioner
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
X5 Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
GW Service not related to the hospice patient's terminal condition
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
23 Unusual anesthesia: occasionally, a procedure, which usually requires either no anesthesia or local anesthesia, because of unusual circumstances must be done under general anesthesia. this circumstance may be reported by adding modifier 23 to the procedure code of the basic service.
77 Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
AQ Physician providing a service in an unlisted health professional shortage area (hpsa)
CC Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed)
GA Waiver of liability statement issued as required by payer policy, individual case
GX Notice of liability issued, voluntary under payer policy
Q0 Investigational clinical service provided in a clinical research study that is in an approved clinical research study
Q6 Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
QJ Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b)
Date
Action
Notes
2015-01-01 Added Added
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"